Position in ABCL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$110,804
-$344,291 QoQ
Shares Held
31,749
-76.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in ABCL
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $110,804 | 31,749 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $455,095 | 133,069 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $515,429 | 102,471 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $49,114 | 14,319 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $41,812 | 18,750 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $169,017 | 57,685 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $34,626 | 13,318 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $203,967 | 68,908 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $211,895 | 46,776 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $296,959 | 52,007 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $238,096 | 51,760 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $803,546 | 124,388 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,194,539 | 158,427 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,001,404 | 197,572 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $482,562 | 48,793 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,324,465 | 124,363 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,821,387 | 186,809 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,148,018 | 80,281 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,132,961 | 56,535 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $513,568 | 23,344 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $531,847 | 15,661 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||